New Owner
GSK (GlaxoSmithKline) - Genelabs Technologies
GSK (GlaxoSmithKline) acquires Genelabs Technologies
Announced: October 29, 2008
Type: Acquisition
Disposition: Subsidiary
Terms: Cash
Status: Complete
Amount: $ 57,000,000